K. Parker

Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells.

K. Parker, A. Barrett, N. Hensel, 1996, Blood.

Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein.

W. Bishai, T. Strom, J. Murphy, 1987, Protein engineering.

human myeloid leukemia cells specific for a peptide derived from proteinase 3 preferentially lyse Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes

A. Barrett, N. Hensel, P. Fukushima, 2011 .

Rat interleukin-2 immunoglobulin M fusion proteins are cytotoxic in vitro for cells expressing the IL-2 receptor and can abolish cell-mediated immunity in vivo.

I. Anegon, J. Soulillou, F. Lang, 1994, Transplantation.

The ultraviolet radiosensitivity of Oedogonium cardiacum cells at various stages of the cell cycle

K. Parker, R. Horsley, 1972 .